Form S-1 BriaCell Therapeutics

Go back to Form S-1 BriaCell Therapeutics

BriaCell Therapeutics (BCTX) Files for 6.83M Share and Warrant Offering

July 8, 2025 4:11 PM UTC

BriaCell Therapeutics (NASDAQ: BCTX) has filed the following:

We are offering on a best efforts basis (the Offering) up to 6,825,938 common units (each, a Common Unit) , each Common Unit consisting of one common share, no par value per share, of BriaCell Therapeutics Corp. and one warrant to purchase one common share (the BCTXZ Warrant). The assumed public offering price for each Common Unit used throughout this prospectus is $2.93, which was the last reported sale price of our common shares on the Nasdaq Capital Market on July... More